logo
AI Icon𝛼SK or Search
ENTITY

OliX Pharmaceuticals (226950 KS)

8
Analysis
Health Care • South Korea
OliX Pharmaceuticals, Inc. operates as a biotechnology and pharmaceutical company. The Company develops ribonucleic acid interference technology, ribonucleic acid interference therapeutics, and pharmaceuticals the treatment of macular degeneration. OliX Pharmaceuticals offers services throughout South Korea.
more
Exchange Announcement • 16 Sep 2026 18:15

Material Management Information related to Judgment of Investment(Application for IND Approval)

Exchange Announcement • 08 Sep 2026 15:06

[Revised] Material Management Information related to Judgment of Investment(Application for IND Approval)(안드로겐성 탈모가 있는 건강한 남성을 대상으로 OLX72021의 ì•ˆì „ì„±ê³¼ ìœ íš¨ì„±ì„ 평가하기 위한 다기관, 무작위 ë°°ì •, 이중 눈가림, 위약 대조, 다중 상승 용량 ì œ1b/2a상 임상시험 계획 ìŠ¹ì¸ì‹ ì²­)

Exchange Announcement • 21 Aug 2026 14:15

Material Management Information related to Judgment of Investment(Hansoh와의 공동연구 및 염기서열 ì´ì „ 계약 ì²´ê²°)

Exchange Announcement • 04 Aug 2026 16:50

[Revised] Material Management Information related to Judgment of Investment(ì¤‘ì¶”ì‹ ê²½ê³„ ì „ë‹¬ì²´ ê¸°ìˆ í‰ê°€ 및 ê¸°ìˆ ë„ìž ì˜µì ˜ 계약 ì²´ê²°)

Exchange Announcement • 30 Jul 2026 14:44

Outcomes of Extraordinary General Meeting of Shareholders

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x